Hepatic arterial chemotherapy for colorectal liver metastases

被引：0

作者：

Mathur, P ^{[1
]}

Allen-Mersh, TG ^{[1
]}

机构：

[1] Chelsea & Westminster Hosp, Dept Gastrointestinal Surg, Imperial Coll, Sch Med, London SW10 9NH, England

来源：

HEPATO-GASTROENTEROLOGY | 2001年 / 48卷 / 38期

关键词：

colorectal liver metastasis; hepatic arterial chemotherapy;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The management of hepatic metastasis from colorectal cancer represents a significant clinical problem. For the majority of patients with colorectal liver metastases, chemotherapy will be the mainstay of treatment. Considerable data now exists to support hepatic arterial chemotherapy as being effective over systemic chemotherapy both in terms of quality of Life and response rates. Morbidity and mortality rates are reduced when catheters are placed by skilled dedicated surgeons using rigorous protocols.

引用

页码：317 / 319

页数：3

共 28 条

[1]

Aigner KR, 1998, SEMIN SURG ONCOL, V14, P248, DOI 10.1002/(SICI)1098-2388(199804/05)14:3<248::AID-SSU9>3.3.CO

[2]

2-9

[3] QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES [J].